MaxCyte, Inc. Payments of Stock Issuance Costs
MaxCyte, Inc. (MXCT) reported Payments of Stock Issuance Costs of $17.60 million for the 3-month period ending 2021-09-30, per its 10-K filed 2023-03-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-11-06
- MaxCyte, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $17.60M.
- MaxCyte, Inc. payments of stock issuance costs for the quarter ending 2021-03-31 was $3.50M.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs as first filed | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 3 month |
|---|---|---|---|---|
| 2021-09-30 | $17.60M 10-K · filed 2023-03-15 | |||
| 2021-08-03 | $17.56M 10-Q · filed 2024-11-06 | $17.60M 10-Q · filed 2023-05-10 | ||
| 2021-03-31 | $3.50M 10-Q · filed 2021-11-10 | |||
| 2021-02-28 | $3.50M 10-K · filed 2023-03-15 | |||
| 2019-03-31 | $1.00M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |